Endothelial cell senescence operates through interconnected pathways involving p53/p21 and p16-mediated cell cycle arrest, accompanied by morphological changes including increased caveolin-1 expression and LaminB1 loss. The senescence-associated secretory phenotype (SASP) emerges as a central mechanism, releasing inflammatory cytokines that perpetuate chronic vascular inflammation. This comprehensive framework represents a significant advance in understanding cardiovascular aging at the cellular level. The integration of classical senescence pathways with newer players like mTOR signaling and regulatory microRNAs provides a more complete picture of how vascular dysfunction develops. For adults concerned with cardiovascular health, this research underscores why chronic inflammation becomes increasingly problematic with age—senescent endothelial cells essentially become inflammatory factories lining our blood vessels. The multidimensional approach moves beyond single-pathway thinking to reveal how cellular aging, inflammatory signaling, and transcriptional regulation converge to drive cardiovascular disease. While this review synthesizes existing knowledge rather than presenting novel experimental data, it offers valuable mechanistic insights that could inform therapeutic strategies targeting endothelial senescence and SASP-mediated inflammation in aging populations.